Pharma Pulse: A call for U.K. pricing reform and the latest FDA-approved biosimilar for bone health
Mar 30, 08:42 PM
Share
Subscribe
In today’s Pharma Pulse, Eli Lilly calls for the U.K. government to overhaul its drug pricing framework and the FDA approves Ponlimsi.